The FDA has granted marketing clearance of the Viz.AI Contact Application, to alert providers of potential stroke in their patients.
Women have worse health-related quality of life and more activity limitations after stroke.
The FDA has expanded the treatment window for a clot retrieval device in certain patients presenting with acute ischemic stroke.
Outcomes in intracerebral hemorrhage are less severe in patients with prior NOAC use.
Care quality varies across elements of care and facilities for patients with TIA or minor stroke.
For adults undergoing non-cardiac surgery, having a PFO is linked with an increased risk of perioperative ischemic stroke.
Effective treatments are needed to address the spastic hypertonia that compromises quality of life for many patients following stroke.
Administration of intravenous tPA is associated with significant improvement in neurologic function following acute ischemic stroke; however, this treatment is associated with increased cost as well as risk for intracranial hemorrhage.
This is the first clinical trial to compare antiplatelet and anticoagulation therapy in patients with cancer and ischemic stroke.
The results confirm that ischemic, hemorrhagic, and subarachnoid stroke have very different etiologies.
Following the MIND diet is associated with slower rates of cognitive decline in individuals who survived stroke.
Although several studies have established the use of endovascular therapy with stent retrievers for selected acute stroke as standard of care, best practices surrounding the best sedation strategy remain unclear.
There is a significant increased risk of coronary heart disease and stroke linked with smoking just 1 cigarette per day.
Many stroke patients referred to rehabilitation services, do not actually receive these services.
Although renal cysts are generally thought of as benign findings, this study points to a possible higher stroke risk in patients with multiple cysts.
Percutaneous patent foramen ovale closure is superior to medical treatment alone in preventing recurrent strokeJanuary 26, 2018
Patent foramen ovale closure was superior to medical treatment alone in preventing transient ischemic attack and recurrent stroke.
Thrombectomy performed between 6 and 24 hours after onset of acute stroke in patients with a mismatch between stroke symptoms and infarct volume results in better disability outcomes compared to standard care alone.
The findings suggest that future studies should explore the specific time window in which SSRIs are beneficial.
Under the new ischemic stroke guidelines, the treatment window for thrombectomy has been expanded to up to 24 hours after symptom onset.
Fixed-dose candesartan plus hydrochlorothiazide and rosuvstatin reduced first stroke in patients at intermediate risk for cardiovascular disease.
In this population-based study, researchers found that Mexican Americans had a greater risk for recurrent stroke and death than non-Hispanic whites.
Researchers have observed an upward trend in the incidence of pregnancy-related spontaneous subarachnoid hemorrhage.
A significantly shorter door-to-needle time is associated with the presence of a pharmacist at bedside during acute ischemic stroke.
Screening for coexisting diseases may help identify high-risk patients with intracranial atherosclerotic disease.
CHA2DS2-VASc score assessment is more predictive of ischemic stroke in patients with atrial fibrillation than the baseline score.
In adults with PFO, percutaneous and transcatheter PFO closure prevent recurrent stroke.
Patients who received adjunctive electrostimulation and task-oriented training had greater improvement than patients who received standard rehabilitation.
Clopidogrel tablets were recalled by International Laboratories due to bottle mislabeling.
Outcome measure scores strongly predict discharge destination after acute, subacute stroke
Higher-quality randomized controlled trials are needed in order to better assess the benefits of PPAR-γ agonists in recurrent stroke risk.
Neurology Advisor Articles
- FDA Approves Expanded Treatment Window for Clot Retrieval Device in Acute Ischemic Stroke
- Genetic and Imaging Markers in Migraine: Ready for Prime Time?
- Resting Tremor Most Common in Early Parkinson Disease
- Intracerebral Hemorrhage-Related Hospital Mortality Reduced With Prior NOAC Use
- Ethical Considerations in New Coma Research
- Updated Ischemic Stroke Guidelines: Expert Takeaways
- Alternative Genetic Risk Variant for Alzheimer Disease Identified
- Advance Directives for Dementia: Honoring Patient Wishes When You Don't Know What They Are
- Ethical Considerations in New Coma Research
- Poor Sleep Associated With Worse PTSD, Chronic Pain in Youth
- Comparing Reference Points for Deep Brain Stimulation Location in Parkinson Disease
- FDA Approves Clinical Decision Support Tool for Stroke
- US Will Produce Radioisotope for MRI, FDA Says
- Cognitive Decline in Men Linked to Low Serum Sodium
- Solanezumab Every 4 Weeks Does Not Significantly Affect Cognitive Decline in Alzheimer Disease